On January 3, 2019 Peloton Therapeutics, Inc., a clinical-stage pharmaceutical company advancing first-in-class oral medicines for cancer and other serious conditions, reported that it will be presenting at the 37th Annual J.P. Morgan Healthcare Conference (Press release, Peloton Therapeutics, JAN 3, 2019, View Source [SID1234532415]). John A. Josey, Ph.D., Chief Executive Officer, will present at 3:30 p.m. PDT on Tuesday, January 8, 2019 at the Westin St. Francis in San Francisco, California.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!